Reference48 articles.
1. Ambani, L. M. and Van Woert, M. H. (1972). Modification of the tremorigenic activity of physostigmine. Br. J. Pharmacol., 46, 344–7.
2. Baker, W. W., Zivanovic, D. and Malseed, R. T. (1975). Contrasting local effects of MAO inhibitors on caudate tremor activities. Eur. J. Pharmacol., 31, 17–22.
3. Baker, W. W., Zivanovic, D. and Malseed, R. T. (1976). Tremorogenic effects of intracaudate d-amphetamine and their suppression by dopamine. Arch. Int. Pharmacodyn. Ther., 223, 271–81.
4. Barar, F. S. K. and Madan, B. R. (1976). Tremorine-oxotremorine induced tremor, hypothermia and analgesia, and physostigmine toxicity, in mice after pretreatment with β-adrenoceptor antagonists. J. Pharm. Pharmacol., 28, 286–9.
5. Bjorkman, S., Castensson, S. and Sievertsson, H. (1979). Tripeptide analogs of melanocyte stimulating hormone release-inhibiting factor (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine tremor. J. Med. Chem., 22, 931–5.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献